Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

N Terminus of Type 5 Adenylyl Cyclase Scaffolds Gs Heterotrimer

Rachna Sadana, Nathan Dascal and Carmen W. Dessauer
Molecular Pharmacology December 2009, 76 (6) 1256-1264; DOI: https://doi.org/10.1124/mol.109.058370
Rachna Sadana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathan Dascal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carmen W. Dessauer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Abstract

According to accepted doctrine, agonist-bound G protein-coupled receptors catalyze the exchange of GDP for GTP and facilitate the dissociation of Gα and Gβγ, which in turn regulate their respective effectors. More recently, the existence of preformed signaling complexes, which may include receptors, heterotrimeric G proteins, and/or effectors, is gaining acceptance. We show herein the existence of a preformed complex of inactive heterotrimer (Gαs·βγ) and the effector type 5 adenylyl cyclase (AC5), localized by the N terminus of AC5. GST fusions of AC5 N terminus (5NT) bind to purified G protein subunits (GDP-Gαs and Gβγ) with apparent affinities of 270 ± 21 and 190 ± 7 nM, respectively. GDP-bound Gαs and Gβγ did not compete, but rather facilitated their interaction with 5NT, consistent with the isolation of a ternary complex (5NT, Gαs, and Gβγ) by gel filtration. The AC5/Gβγ interaction was also demonstrated by immunoprecipitation and fluorescence resonance energy transfer (FRET) and the binding site of heterotrimer Gαs·βγ mapped to amino acids 60 to 129 of 5NT. Deletion of this region in full-length AC5 resulted in significant reduction of FRET between Gβγ and AC. 5NT also interacts with the catalytic core of AC, mainly via the C1 domain, to enhance Gαs- and forskolin-stimulated activity of C1/C2 domains. The N terminus also serves to constrain Gαi-mediated inhibition of AC5, which is relieved in the presence of Gβγ. These results reveal that 5NT plays a key regulatory role by interacting with the catalytic core and scaffolding inactive heterotrimeric G proteins, forming a preassembled complex that is potentially braced for GPCR activation.

Footnotes

  • ↵Embedded Image The online version of this article (available at http://molpharm.aspetjournals.org) contains supplemental material.

  • This research was supported by the National Institutes for Health National Institute of General Medicine [Grants GM060419, GM68493], the American Heart Association [Grant 09GRNT2200034]; and the U.S.-Israel Binational Science Foundation [Grant 01-122].

  • Article, publication date, and citation information can be found at http://molpharm.aspetjournals.org.

    doi:10.1124/mol.109.058370

  • ABBREVIATIONS:

    AC
    adenylyl cyclase
    NT
    N terminus
    AKAP
    A-kinase anchoring protein
    GPCR
    G protein-coupled receptor
    FRET
    fluorescence resonance energy transfer
    GIRK
    G protein-coupled inwardly rectifying potassium channel
    PLC
    phospholipase C
    GTPγS
    guanosine 5′-O-(3-thio)triphosphate
    5NT
    AC5 N terminus
    6NT
    AC6 N terminus
    PCR
    polymerase chain reaction
    aa
    amino acid(s)
    GST
    glutathione transferase
    YFP
    yellow fluorescent protein
    HEK
    human embryonic kidney
    DTT
    dithiothreitol
    C12E9
    nonaethylene glycol monododecyl ether
    PAGE
    polyacrylamide gel electrophoresis
    IP
    immunoprecipitation
    CFP
    cyan fluorescent protein
    FRETC
    corrected, sensitized FRET
    Cer
    Cerulean.

    • Received June 10, 2009.
    • Accepted September 24, 2009.
  • © 2009 The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 76 (6)
Molecular Pharmacology
Vol. 76, Issue 6
1 Dec 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
N Terminus of Type 5 Adenylyl Cyclase Scaffolds Gs Heterotrimer
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

N Terminus of Type 5 Adenylyl Cyclase Scaffolds Gs Heterotrimer

Rachna Sadana, Nathan Dascal and Carmen W. Dessauer
Molecular Pharmacology December 1, 2009, 76 (6) 1256-1264; DOI: https://doi.org/10.1124/mol.109.058370

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

N Terminus of Type 5 Adenylyl Cyclase Scaffolds Gs Heterotrimer

Rachna Sadana, Nathan Dascal and Carmen W. Dessauer
Molecular Pharmacology December 1, 2009, 76 (6) 1256-1264; DOI: https://doi.org/10.1124/mol.109.058370
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Mechanism of the selective action of paraherquamide A
  • Fatty Acid Amide Hydrolase in Cisplatin Nephrotoxicity
  • Use-Dependent Relief of A-887826 Inhibition
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics